Development of effective therapeutics for brain disorders is challenging, in particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma. Traumatic brain injury (TBI) may lead to transient BBB permeability that affords a unique opportunity for therapeutic delivery via intravenous administration ranging from macromolecules to nanoparticles (NP) for developing precision therapeutics. In this regard, we address critical gaps in understanding the range/size of therapeutics, delivery window(s), and moreover the potential impact of biological factors for optimal delivery parameters. Here we show, for the first time, to the best of our knowledge, that 24 h post-focal TBI female mice exhibit a heightened macromolecular tracer and NP accumulation compared to male mice, indicating sexdependent differences in BBB permeability. Furthermore, we report for the first time the potential to deliver NP-based therapeutics within 3 d after focal injury in both female and male mice. The delineation of injury-induced BBB permeability with respect to sex and temporal profile is essential to more accurately tailor time-dependent precision and personalized nanotherapeutics.
Introduction
Development of effective therapeutics for brain disorders, such as traumatic brain injury (TBI), remains a major clinical challenge [1] [2] [3] [4] . In particular, the blood-brain barrier (BBB) severely limits access of the therapeutics into the brain parenchyma 1, 3 . Due to its highly selective nature, the BBB constitutes the greatest impediment for drug delivery via blood circulation to treat brain disorders. As such, several active drug delivery strategies such as transient BBB disruption via focused ultrasound and convectionenhanced delivery are being explored in preclinical settings to facilitate drug/macromolecules to cross or bypass the BBB 5 . These tools are useful, yet, certain neural pathologies may naturally afford the ability to exploit periods of enhanced BBB permeability for enabling drug delivery to the parenchyma. For example, TBI may lead to a transient BBB disruption, that affords a unique opportunity for the development of precision therapeutics via intravenous administration, thus facilitating a spectrum of therapeutics ranging from macromolecules to nanoparticles (NPs). However, there is a critical gap in understanding the permissible range/size of therapeutic agents, optimal delivery window(s), and moreover the potential impact of biological factors on BBB permeability after a TBI and ultimately therapeutic delivery parameters. Therefore, in this study, we characterize three crucial factors (1) size range (macromolecules vs NPs) for therapeutics, (2) their temporal profiles (acute and sub-acute post-injury delivery), and (3) sex dependence (female vs male) that can directly influence the accumulation within injured brain tissue.
Brain injury is characterized by structural failure and neurologic dysfunction that begins at the time of impact and lasting for hours to weeks 6, 7 . The primary injury is the direct result of the initial trauma of a TBI and leads to an indirect secondary injury, a cascade of neural and vascular events including inflammation, excitotoxicity, hypoxia, edema, and BBB disruption 6, 7 . The secondary injury develops over hours and days following a TBI allowing a time window for intervention. Most consequences of BBB disruption after brain injury are known to be detrimental, yet the disruption may also provide a transient window for delivery of therapeutics that normally would not cross this barrier from the systemic circulation [8] [9] [10] [11] . Macromolecules such as specific antibodies and proteins have been identified as promising therapeutic agents for the treatment of various brain pathologies 1, 12 . These therapeutic agents can exert numerous biological actions in the brain such as regulation of cerebral blood flow, neurotransmission, and neuromodulation 12 . Furthermore, in recent years, NPs have been used extensively to serve as carriers for improved drug stability, pharmacokinetics, and therapeutic efficacy with reduced toxicity [13] [14] [15] [16] [17] [18] [19] . The above-mentioned classes of therapeutics including proteins 20, 21 and NPs 22, 23 have been approved by the US Food and Drug Administration for clinical use for other diseases/pathologies. However, there is a critical gap in understanding the utility of using both of these classes of therapeutics for brain injury since the delivery parameters for optimal and personalized delivery (i.e. the impact of biological factors) have not been previously investigated. Therefore, in this pre-clinical study, we use large molecular weight protein tracers (~40 kDa, horseradish peroxidase) and NPs (~40 nm, PEGylated fluorescent polystyrene nanoparticle) to address this critical gap and as a proof of concept to characterize the delivery profile to the injured brain tissue via the disrupted BBB.
Previously, we and others have established in both focal and diffuse injury models of TBI that macromolecular weight tracer (~40 kDa) 19, [24] [25] [26] and NPs 10, 19, [26] [27] [28] robustly accumulate within injured brain tissue in the first 4h following TBI. Moreover, seminal TBI studies in male rodents suggest a biphasic BBB opening to macromolecular weight tracers with the first peak at acute (~3-6h) time points followed by a delayed opening (~3 d) after TBI 25, 29 . However, the potential to deliver larger therapeutics such as NPs beyond 24 h post-injury has not been investigated.
Furthermore, sex differences are known to play a role in the morbidity and mortality after TBI 30, 31 , yet the underlying mechanisms are not well elucidated. Sex-specific preclinical studies have reported less BBB disruption in female rodents compared to males within 6h of injury 32, 33 but no difference 24 h and 7 d post-injury 34, 35 . However, sex differences in BBB disruption during clinically important sub-acute time points between 24 h and 7 d after TBI have not been studied. Taken together, this study aims to characterize therapeutic window for delivery of large molecular weight tracer and NPs beyond 24 h post-injury. Moreover, we aim to evaluate potential sex-dependent differences in BBB disruption and subsequent large molecular weight tracer and NP accumulation following TBI. Ultimately, we reveal not only an extended NP delivery window but also key sex-dependent considerations for both large molecular weight tracer and NP delivery strategies following TBI.
Results
The lateral controlled cortical impact (CCI) imparts an injury directly to the frontoparietal cortex generating a cortical lesion ipsilateral to the impact with no direct damage to the contralateral hemisphere. Brain injury may lead to a transient BBB disruption that could potentially allow therapeutic delivery to the injured brain regions.
See Supplementary Fig S1 for experimental design/timeline. The focus of this study is three fold: (1) to investigate delivery dynamics of macromolecules and NPs, (2) to determine acute and sub-acute temporal delivery profiles, and (3) to examine sex dependence for delivery of these therapeutic agents. To examine the potential delivery of the macromolecules, a large molecular weight (MW) tracer, horseradish peroxidase (HRP, 40 kDa), was used as a surrogate [36] [37] [38] . Each cohort received intravenous HRP injection 10 mins prior to sacrifice at 3 h, 24 h, 3 d, 7 d following CCI injury. The HRP extravasation was analyzed at the core of the injury (~ -1.65 mm Bregma). The extravasation of HRP at 3 h, 24 h and 3 d time points was restricted to the primary injury region (Fig 1a) . We observed no HRP staining in the contralateral hemisphere for any time point post-injury ( Supplementary Fig S2) . Twoway ANOVA analysis revealed a significant main effect of both hemisphere (p<0.0001) and time (p<0.0001) on HRP levels for both female and male cohorts (Fig 1b and 1c , respectively); a significant interaction between hemisphere and time was also discovered (p<0.0001) (Supplementary Table 1 Interestingly, the male 3 d (ipsilateral) cohort showed a significant increase (~150% increase) in HRP staining relative to the 24 h male ipsilateral group.
Extravasation of intravenously injected macromolecular tracer (horseradish peroxidase) after focal brain injury:
A two-way ANOVA revealed a significant main effect for both sex (p=0.0004) and time (p<0.0001) on ipsilateral HRP levels (Fig 1d) ; the interaction between sex and time was also significant (p=0.0119) (Supplementary Table 1 for statistical details).
Specifically, at 24 h post-injury, there was significantly increased HRP staining in females compared (3 x higher) to their male counterparts (p= 0.0002). This observation supported the previously reported biphasic BBB disruption pattern for male cohorts 25, 29 .
However, more intriguingly, the females exhibited consistent HRP staining levels at both 24 h and 3 d post-injury, not following a biphasic response. Taken together, the extravasation of the macromolecular tracer was observed acutely (3 h and 24 h) and sub-acutely (3 d) post-injury, demonstrating a potential for delayed therapeutic macromolecule delivery. Furthermore, more strikingly, the macromolecular tracer delivery was sex-dependent, where only the males showed a biphasic pattern. To examine the potential NP delivery at acute and sub-acute time points and the sex dependence for delivery after brain injury, we used fluorescent PEGylated 40 nm polystyrene NPs (See Supplementary Fig S3 for NP characterization). Each cohort received an intravenous injection of the NPs three hours before sacrifice (See Supplementary Fig S4 for biodistribution data). Mirroring HRP analysis, the area of NP accumulation was quantified at the core of the injury (~ -1.65mm Bregma) via an epifluorescent microscope. NP accumulation was restricted to the primary injury region ( Fig. 2 (a) ), similar to the HRP staining. We observed no detectable NP accumulation in the contralateral hemisphere for any time point post-injury (See Supplementary Fig S5) .
Accumulation of intravenously injected nanoparticles after focal brain injury
Briefly, we found significant NP delivery for females acutely at 3 h and 24 h and subacutely at 3 d post-injury. However, for males, the NP accumulation was significantly increased in the ipsilateral hemisphere compared to the contralateral hemisphere only at 3 h for acute delivery and at 3 d for sub-acute delivery. Moreover, there was a significantly higher NP accumulation at 24 h post-injury in females compared to males ( Fig. 2 (b); 2.5 x higher). These results trended similar to HRP extravasation. Two-way ANOVA showed a significant main effect for both the hemisphere (p<0.0001) and time (p<0.0001) on HRP extravasation in both female ( Fig. 2 (b) ), and male cohorts ( Fig. 2 (c) ); the interaction between hemisphere and time was also significant (p<0.0001) (Supplementary Table 2 To investigate the sex dependence for NP delivery, we used two-way ANOVA to compare the female and male ipsilateral hemispheres across time points. Overall, the analysis revealed a significant interaction effect between sex and time (p=0.0087) with a significant main effect of time on NP accumulation (p<0.0001), but no main effect of sex on NP accumulation (p=0.2402) (Supplementary Table 2 for statistical details). A posthoc pair-wise analysis at 24 h showed a significantly increased NP accumulation in females compared to males (p=0.0437), comparable to the HRP extravasation profile.
Overall, we found significant NP accumulation in the ipsilateral hemisphere at acute and
sub-acute time points in both female (3 h, 24 h, and 3 d) and male (3 h and 3 d) cohorts
compared to the contralateral hemisphere. Furthermore, the ipsilateral hemisphere of the females showed significantly increased NP accumulation at 24 h post-injury compared to the male cohort. For each animal, a single two-photon video recording session was conducted for a maximum of 3 h after NP injection within the injury penumbra with as a minimum one scan per hour lasting at least 5 mins per scan. Overall, at least three different locations were imaged focusing on regions with identifiable, semi-intact blood vessels (See Supplementary Fig S6) . Representative still images in Fig 3 (a) , and supplementary videos show NP (in red) and the CX3CR1-GFP + cells (microglia/macrophage; green). In the sham animals, we observed intact large blood vessels with the NP fluorescence and no NP extravasation, surrounded by ramified microglia (Fig 3 (b) ). Additionally, we observed activated microglia with amoeboid morphology at 24 h and 3 d post-injury that corroborates previous studies [39] [40] [41] . We did not observe any detectable NP intensity within the extravascular tissue at 7 d post-injury in either sex. 42, 43 . By 3-4 d, this hyperintensity is reduced, suggesting the acute edema is resolving 42, 43 . At 7 d, there is typically an area of signal hyperintensity at the center of the injury region, usually interpreted as an area where tissue has been lost and replaced by fluid 42, 43 . Two-way ANOVA analysis showed no significant interaction between sex and time (p = 0.8084); yet, a significant main effect of both sex (p = 0.0017) and time (p = 0.0001) on lesion volume was identified ( Supplementary Table 3 for statistical details). Pair-wise post-hoc analysis showed no significant differences Supplementary Fig S7. Two-way ANOVA showed significant interaction between location (hemisphere) and time (p<0.0026, p<0.0002) and also a significant main effect for both hemisphere (p≤0.0002, p<0.0001) and time on GFAP immunostaining (p<0.0047, p<0.0001), respectively for female ( Fig. 5 (b) ), and male cohorts ( Fig. 5 (c) ) (Supplementary Table 4 for statistical details). We observed minimal GFAP expression at 3 h and 24 h post-injury for both female and male mice. For the female cohort, pairwise analysis revealed significantly increased GFAP staining ipsilaterally at 3 d (p<0.0001) post-injury compared to the contralateral hemisphere. For the male cohort, a significant increase in GFAP staining was detected at 3 d (p <0.0001) and 7 d (p=0.0127) post-injury compared to their respective contralateral location. To investigate the sex dependence, a two-way ANOVA revealed a no significant interaction between sex and time nor a main effect of sex. Time was identified as a significant main effect on GFAP immunostaining levels (p<0.0001) ( Fig 5 (d) ). Taken together, the results show no significant sex difference in GFAP expression at any time point post-injury.
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Injury lesion volume analysis: MRI analysis
Discussion
The blood-brain barrier (BBB) is a unique element of the brain that regulates molecular transport from the bloodstream to the brain parenchyma. Although the BBB disruption after TBI is thought to be detrimental, such opening may provide an opportunity for the delivery of drugs and therapeutics via NPs. To fully utilize the window of opportunity of BBB opening after TBI, a thorough assessment of the temporal resolution and the sex dependence of macromolecule for NP accumulation via the BBB was warranted. In this study, we directly address the critical gap using a focal TBI Placing our data in context with prior studies that investigate differential sex responses to TBI, the following points are critical to consider. At our most acute (3 h) time point post-injury, we observed a peak accumulation of HRP and NP in both sexes with no significant sex differences. The controlled cortical impact model, consistently produces cortical damage including tearing of the dura, parenchyma and severe vascular disruption directly at the site of impact 29, 44 . Our findings of no sex differences 3 h post-injury in HRP and NP accumulation support mechanical disruption of the BBB from the primary impact. Comparing our data with previous studies using a diffuse TBI model, minimal BBB opening in intact (normal cycling) females was reported compared to significant BBB disruption in males at 5h post-injury 32, 33 . At 24 h post-injury, a sexdependent BBB disruption emerged. Specifically, the females displayed a robust HRP/NP accumulation that was nearly 2.5-3x than their male counterparts. Although previous reports using different injury model 34 and endogenous marker 35 reported no sex differences in the BBB permeability at 24 h post-injury. The contrast between studies highlights the importance of considering injury phenotype (diffuse vs focal) and molecular tracer when comparing BBB disruption profiles. Notably, we designed our study to capture the dynamics of macromolecule and NP extravasation at distinct phases post-injury by intravenously injecting exogenous markers of NP (3 h) and HRP (10 mins) prior to sacrifice and perfusion at distinct time points post-injury. Moreover, the males showed a biphasic trend with a significant decrease in HRP/NP at 24 h compared to 3 h and 3 d post-injury, in alignment with previous seminal studies in male rodents using large molecular weight tracer 25, 45 . At sub-acute (3 d) time point, we observed significant macromolecular tracer and NP accumulation in both female and male cohorts compared to their respective contralateral region. Delayed BBB disruption is mainly associated with the secondary injury that follows the primary injury, although the mechanism(s) have not been clearly elucidated 9, 46 . Evidence suggests increased paracellular permeability due to disruption of tight junction complexes and integrity of the basement membrane as a dominant mechanism 9, 46, 9, 47 . Oxidative stress due to reactive oxygen species (ROS) and free radical production after brain trauma alter the critical organization of tight junction proteins at the BBB resulting in increased paracellular leakage 9, 48 . Additionally, the disruption of vasculature and brain tissue caused by the primary impact triggers the coagulation cascade and leads to oxidative stress with increased production of proinflammatory mediators 9, 46 . These pathophysiological processes initiate glial cell activation and alter their interaction with the cerebrovascular endothelial cells potentially further contributing to BBB dysfunction 9, 46, 49, 50 . Taken together, to the best of our knowledge, this is the first report showing that the BBB disruption is sex-dependent for macromolecule and NP extravasation.
One of the key findings of our study is the differential sex response at 24 h postinjury between the macromolecular tracer (3 x higher) and NP accumulation (~2.5 x higher) in females compared to males. These results were obtained from cohorts with no significant sex-dependent variations in astrogliosis and lesion volume. Numerous pre-clinical TBI studies report a female neuroprotective effect implicating estrogen or progesterone mediated mechanisms 58-61 , but a few studies report no impact of sex on the outcome 62, 63 . In contrast, clinical studies cite worse outcomes for females compared to males [64] [65] [66] [67] [68] . Our study design mirrored prior work that indicated that the phase of the estrous cycle at the time of injury does not significantly affect functional outcomes following TBI 69 . Yet, future studies are warranted as a study by Maghool et. al. in rats reported females in proestrus phase are less vulnerable to brain injury compared with females in non-proestrus phase as measured by levels of brain edema and intracranial pressure 70 . Furthermore, it is important to recognize that a TBI event may alter subsequent sex hormone levels thereby affecting estrous cycles acutely after injury. A pre-clinical rat study shows evidence that TBI leads to disruption of the estrous cycle with significantly reduced 17ߚ-estradiol (E2) hormone level 71 and spatial memory impairment compared to the sham group. Similarly, clinical studies indicate that TBI affects the circulating serum hormone levels in both females and males 72, 73 . In females, testosterone increased with modest/no increase in estrogens 72 . In males, estrogen increases with a decrease in testosterone 73 . Therefore, specific studies to understand the role of sex hormones in neuroprotection and BBB breakdown after TBI are warranted.
In conclusion, to the best of our knowledge, we report for the first time that (1) female mice exhibit a robust macromolecular tracer (3 x higher) and NP accumulation (2.5 x higher) at 24 h time point after focal TBI compared to male mice, primarily due to sex differences in BBB permeability in response to the injury and (2) we demonstrate the ability to delivery macromolecules and NPs at sub-acute time point (3 d) after focal injury in both female and male mice. The implications of our novel findings are farreaching for personalized and precision medicine. The sex differences in macromolecular and NP extravasation may impact the pharmacokinetics and pharmacodynamics of the therapeutic delivery after brain injury. Moreover, the sex-based differences in extravasation may influence the drug dose, drug concentration and desired bioavailability near the injured brain tissue between female and male subjects.
Therefore, a better understanding of the sex differences is essential to appropriately conduct a risk assessment and to design safe and effective treatments. Future studies to elucidate the underlying hormonal and sex-related differences for variable BBB permeability are warranted.
Materials and methods
Materials
Carboxylated polystyrene NPs of 40 nm (F8793) size with red (λ ex /λ em =580 nm/605 nm) was purchased from Life Technologies (Carlsbad, CA, USA). 
Nanoparticle PEG conjugation
As presented in our previous study 19, 26 , carboxylated NPs were PEGylated using EDC/NHS chemistry. Briefly, mPEGamine 2 kDa was mixed with 40 nm (NH 2 : COOH at 5:1 mole excess). EDC/NHS (in MES buffer) was added to NP / PEG mixture (200 mM/100 mM) and HEPES buffer was added to obtain a final pH of 7.8 before incubating for 3 h at room temperature. Glycine (100 mM) was added to quench the reaction.
Unbound PEG was removed via dialysis (20 kDa MW). PEGylated NPs were suspended in a 20 mM HEPES (pH 7.4). The concentration of NP solution was determined with fluorescent standard curves generated from known concentrations of as-received Fluorospheres (FLUOstar Omega fluorescence plate reader; BMG Labtech, Ortenberg, Germany). Yields of NPs ranged between 40-60 %. A concentration of 12.5 mg/mL for each NP was used for all in vivo studies.
Nanoparticle characterization
The size (in nanometers) and surface charge (zeta potential in millivolts) of the pre-and post-PEGylation of NPs were evaluated using a Zeta Sizer Nano-ZS (Malvern Instruments, Malvern, UK). Each NP sample in 20 mM HEPES (pH 7.4) was measured three times consecutively. Three measurements were made and the mean ± standard deviation (s.d.) was reported. To study the stability of the NP for 3 h post-injection, unPEGylated NPs and PEGylated NPs were diluted in serum (incubated at 37°C and 5% CO 2 for at least 2h before use) at a concentration comparable to the in vivo blood concentration (0.42 mg/ml). The samples were then incubated in a 96-well plate at 37°C and 5% CO 2 incubator for a about 3 h and the aggregation was monitored by measurement of absorbance at 320 nm at 37°C.
NMR characterization
The conjugation of PEG and the total quantity on NP was detected by 1 H NMR spectra analysis using a previously published methodology 74 . PEGylated and unPEGylated polystyrene NPs were weighed and fully dissolved in a mixture of chloroform (CDCl 3 , Sigma), trifluoroacetic acid-d (TFAd, Sigma), and a known concentration BTSB (0.5% w/v). 1 H NMR spectra were obtained at 400 MHz using a Varian Inc. (Palo Alto, CA, USA) VNMRS 500 MHz NMR spectrometer with a 5 mm ID-PFG probe. PEG2000 polymer (3.6 ppm) was dissolved in the same CDCL 3 -TFAd solvent with BTSB (0.5% w/v) was made at different concentrations to obtain a calibration curve. Total PEG quantity in the PEGylated NP was calculated using the calibration curve.
Animals
Female and male adult C57BL/6 mice (Jackson Laboratory) aged 8-10 weeks 
Controlled cortical impact model
Traumatic brain injury (TBI) was modeled using the well-established controlled cortical impact (CCI) injury model 75 . Briefly, anesthetized (isoflurane) adult mice were mounted onto a stereotaxic frame. The frontoparietal cortex was exposed via 3-4 mm craniotomy and the impact tip was centered to the craniectomy. The impactor tip diameter was 2 mm, the impact velocity was 6.0 m/s and the depth of cortical deformation was 2 mm and 100 ms impact duration (Impact ONE; Leica Microsystems).
The skin was sutured and the animals were placed in a 37°C incubator until consciousness was regained. The sham group went through the same protocol but did not receive the impact injury.
Nanoparticle (NP) and horseradish peroxidase (HRP) injection
Retro-orbital injections of the venous sinus in the mouse, an alternative technique to tail-vein injection 76 
Quantification of HRP extravasation
The tissue section was incubated in PBS buffer for 20 mins at room temperature to obtain the total number of positive pixels per ROI.
Quantification of NP accumulation
For NP analysis, similar to HRP analysis, slides containing the frozen sections were incubated at room temperature for 20 mins in 1X PBS to rehydrate the tissue and remove OCT compound. Coverslips were mounted on the section after adding one drop of fluorescent mounting media (Vectashield). The tissue sampling regions were ~-1.65 mm Bregma and ipsilateral cortex (four sections per animal; n = 4) and contralateral cortex (two sections per animal, n = 4) were imaged with conventional epi-fluorescent microscopy at 10 X objective. All images were taken at the same exposure time and consistent acquisition settings. Similar to HRP analysis, a region of interest 5.2 mm ൈ 2.5 mm was selected around the injury penumbra including the cortical and the hippocampus regions. The ROI images were then analyzed using ImageJ software (National Institute of Health, Bethesda, MD, USA). A threshold was set using images from sham cohort tissues to remove background noise and was kept constant for ipsilateral and contralateral image analysis. The thresholded images were used to obtain the total number of positive pixels per ROI.
Two-photon microscopy: Cranial window placement and Imaging
Transgenic mice (female and male) underwent the CCI injury induction as described above. Based on the imaging time points (immediately after the injury or at 24 h, 3 d, or 7 d post-injury), anesthetized animals received intravenous NP injections (30 mg/kg b.w., 50 μ L; retro-orbital). Following the injection, a cranial window was placed for imaging. The cranial window protocol is modified from a previously published protocol 77, 78 . Briefly, the craniectomy/injury region was cleaned using saline and gel foam soaked in saline was applied to stop any bleeding (if any). The region around the craniectomy was dried using a cotton swab. After ensuring no bleeding, 5 mm diameter glass coverslip was gently placed on the brain tissue, centered at -2 mm bregma and 2 mm lateral midline, Fig. S6 (a-b) . The glass coverslip was sealed using dental cement to secure it and to create a well for the water-immersion objective. One cohort of control, sham animals were used to establish baseline NP extravasation. These sham animals were anesthetized, injected with NPs, then subjected to craniectomy (4 mm), and mins before sacrifice. Animals were perfused using the protocol explained above.
MRI lesion volume analysis
MRI was performed longitudinally at 3 h, 24 h, 3-4 d (3 d for male cohort and 4 d for female cohort) and 7 d post-injury using ParaVision software on a Bruker Biospin 7T system (Bruker Biospin Corp., Billerica, MA). A volume transmitter coil (72 mm) was used in conjunction with a mouse brain surface coil for signal detection. Animals were placed at a prone position on a nonmagnetic holder with the teeth bar as an aid to fix the head position. During image acquisition, anesthesia was maintained using isoflurane (1.5 %) while the body temperature was maintained at 37 o C using a circulating water blanket. Respiration and rectal temperature were monitored using SAI system. T2 weighted scans were acquired using a fast-spin echo sequence (TR/TE/ETL= 4000 ms /60 ms /8, resolution of 0.1 mm X 0.1 mm X 0.5 mm, 30 slices).
The T2-weighted scans were then imported into ImageJ for lesion volume analysis. For each scan, freehand ROIs were drawn around the injury for each slice. The ROI/injury was determined by visually evaluating the area of signal hyperintensity around the location where the cortical impact occurred. The lesion volume was computed for a scan by summing the area of the ROIs of each slice of that scan in terms of the number of voxels. This volume was found for each animal for each time point. PBS. Slides were then incubated for two hours in 1:500 donkey anti-goat 647 secondary with 2 % horse serum in 1X PBS in dark. Finally, slides were stained with DAPI, mounted with vectashield and sealed with nail polish. Slides were imaged at 20 X on the Zeiss LSM800 Laser scanning confocal microscope. The region of interest for imaging was selected at the penumbra region of the injury site, ~200-500 μ m away from the lesion site to avoid the necrosis region. DAPI and GFAP image acquisition settings were held constant. Images were taken around the injury and on the contralateral hemisphere. The percent area was calculated using ImageJ. A threshold was set using tissues from secondary control images to remove background noise and was kept constant for ipsilateral and contralateral images. The thresholded images (ipsilateral and contralateral) were quantified using analyze particles. The percent area result was then averaged per animal.
Immunohistochemical staining, imaging and quantification
Statistics
Statistical analyses were conducted in GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla CA). For HRP, NP, and GFAP analysis, an ordinary two-way ANOVA was conducted to analyze female and male cohorts individually. If there was a significant main effect of hemisphere (ipsilateral vs contralateral) and/or significant interaction effect, the two-way ANOVA analysis was followed by a post-hoc Bonferroni's multiple comparison tests. To evaluate the sex dependence for HRP, NP, and GFAP analysis, an ordinary two-way ANOVA was conducted using ipsilateral hemispheres of female and male cohorts. If there was a significant main effect of sex (female vs male) and/or significant interaction effect, the two-way ANOVA analysis was followed by a post-hoc Bonferroni's multiple comparison tests. For MRI analysis, a two-way ANOVA with replication was conducted to analyze the effect of both time and sex on injury lesion volume. If there was a significant main effect of sex (female vs male) and/or significant interaction effect, the two-way ANOVA analysis was followed by a post-hoc Bonferroni's multiple comparison tests.
